| Particulars |
|
|
|
| Company Name
| Glaxosmithkline Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
169.41 |
B.V. (₹) |
100.50 |
| Sales(₹ Cr.) |
3,723.49 |
NP (₹ Cr.) |
865.43 |
| NP Var (%) |
33.00 |
Div% |
540.00 |
| CPS(₹) |
55.00 |
EPS (₹) |
51.10 |
| Traded Value(₹ Lakhs) |
54.22 |
52 Week High |
3,516.00 |
| 52 Week Low |
1,924.00 |
Price BSE |
2,349.00 |
| P/C Ratio |
42.70 |
P/E Ratio |
46.00 |
| Price Vs.BV |
23.37 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
973.63 |
| NP(₹ Cr.) |
253.08 |
NP Var % |
3.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
3,526.90 |
| OPM |
24.25 |
NP |
795.84 |
| NP Var (%) |
18.93 |
EPS |
55.87 |
| PE |
42.04 |
|
|